| Product Code: ETC8537128 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Dyskinesia Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Dyskinesia Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Dyskinesia Market - Industry Life Cycle |
3.4 Netherlands Dyskinesia Market - Porter's Five Forces |
3.5 Netherlands Dyskinesia Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Netherlands Dyskinesia Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 Netherlands Dyskinesia Market Revenues & Volume Share, By End-User, 2021 & 2031F |
3.8 Netherlands Dyskinesia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Netherlands Dyskinesia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Dyskinesia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of dyskinesia in the Netherlands |
4.2.2 Growth in research and development activities for dyskinesia treatments |
4.2.3 Aging population leading to higher prevalence of dyskinesia |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of dyskinesia medications |
4.3.2 Limited availability of specialized healthcare professionals for dyskinesia treatment |
4.3.3 High cost associated with dyskinesia medications and therapies |
5 Netherlands Dyskinesia Market Trends |
6 Netherlands Dyskinesia Market, By Types |
6.1 Netherlands Dyskinesia Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Dyskinesia Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Netherlands Dyskinesia Market Revenues & Volume, By Athetosis, 2021- 2031F |
6.1.4 Netherlands Dyskinesia Market Revenues & Volume, By Chorea, 2021- 2031F |
6.1.5 Netherlands Dyskinesia Market Revenues & Volume, By Levodopa-induced or Parkinsons Dyskinesia, 2021- 2031F |
6.1.6 Netherlands Dyskinesia Market Revenues & Volume, By Tardive or Delayed Dyskinesia, 2021- 2031F |
6.1.7 Netherlands Dyskinesia Market Revenues & Volume, By Myoclonus Dyskinesia, 2021- 2031F |
6.2 Netherlands Dyskinesia Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Dyskinesia Market Revenues & Volume, By Dopamine-depleting, 2021- 2031F |
6.2.3 Netherlands Dyskinesia Market Revenues & Volume, By GABA Receptor Agonists, 2021- 2031F |
6.2.4 Netherlands Dyskinesia Market Revenues & Volume, By Anti-cholinergics, 2021- 2031F |
6.2.5 Netherlands Dyskinesia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Dyskinesia Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Dyskinesia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Netherlands Dyskinesia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 Netherlands Dyskinesia Market Revenues & Volume, By CROs, 2021- 2031F |
6.3.5 Netherlands Dyskinesia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Netherlands Dyskinesia Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Dyskinesia Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Netherlands Dyskinesia Market Revenues & Volume, By Parenterals, 2021- 2031F |
6.4.4 Netherlands Dyskinesia Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Netherlands Dyskinesia Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Dyskinesia Market Revenues & Volume, By Online Distribution, 2021- 2031F |
6.5.3 Netherlands Dyskinesia Market Revenues & Volume, By Offline Distribution, 2021- 2031F |
7 Netherlands Dyskinesia Market Import-Export Trade Statistics |
7.1 Netherlands Dyskinesia Market Export to Major Countries |
7.2 Netherlands Dyskinesia Market Imports from Major Countries |
8 Netherlands Dyskinesia Market Key Performance Indicators |
8.1 Patient satisfaction scores with dyskinesia treatment options |
8.2 Number of clinical trials and research studies conducted on dyskinesia in the Netherlands |
8.3 Percentage of healthcare facilities offering specialized dyskinesia treatment services |
8.4 Adoption rate of innovative technologies in dyskinesia management |
8.5 Number of partnerships and collaborations between pharmaceutical companies and healthcare providers for dyskinesia treatment. |
9 Netherlands Dyskinesia Market - Opportunity Assessment |
9.1 Netherlands Dyskinesia Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Netherlands Dyskinesia Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 Netherlands Dyskinesia Market Opportunity Assessment, By End-User, 2021 & 2031F |
9.4 Netherlands Dyskinesia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Netherlands Dyskinesia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Dyskinesia Market - Competitive Landscape |
10.1 Netherlands Dyskinesia Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Dyskinesia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here